Experimental MS Drug Withdrawn From Trial

Links shared publicly online about this topic.

  • 1,861
    total visits

Experimental MS Drug Withdrawn From Trial

medicalnewstoday.com

An experimental treatment for multiple sclerosis (MS) has been withdrawn from clinical trials after it failed to delay progression of the condition in a late-stage trial. Dirucotide, manu

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Clinical Trial

  • Share

Most Recently Shared on July 30, 2009 at 12:45 am By:

LisaEmrich Lisa Emrich

MedNewsToday: Experimental MS Drug Withdrawn From Trial: An experimental treatment for multiple scl.. http://bit.ly/11uRup

3 years ago...

2 Treatments for Retina Diseases Make Progress - NYTimes.com

nytimes.com — “In trials, an experimental drug for macular degeneration succeeded in requiring fewer injections. And a therapy from embryonic stem cells won approval for testing to treat retina disease.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 11:15 am By:

hrana Hisham Rana, MD Doctor and Physician

News: 2 treatments for retina diseases make progress http://nyti.ms/cbMdDi - #health

1 year ago...

2 Treatments for Retina Diseases Make Progress - NYTimes.com

nytimes.com — “In trials, an experimental drug for macular degeneration succeeded in requiring fewer injections. And a therapy from embryonic stem cells won approval for testing to treat retina disease.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 5:46 am By:

Health_CK Catherine K Health Advocate

2 Treatments for Retinas Make Gains: In trials, an experimental drug for macular degeneration succeeded in requ... http://nyti.ms/creGSx

1 year ago...

Target Cancer - Series - The New York Times

topics.nytimes.com — “Articles in the Target Cancer series from The New York Times.View full resource at topics.nytimes.com

  • View Related
  • Share

Most Recently Shared on February 26, 2010 at 5:23 am By:

stupidcancer Matthew Zachary Patient Expert

@NYTimes "Target Cancer" series chronicles first human trial of experimental @StupidCancer drug. #fascinating http://nyti.ms/a7Y0hU

2 years ago...

Advertisement